Life ScienceCompany
Abzena has acquired 2 companies of its own.
Abzena’s largest acquisition to date was in 2015, when it acquired PacificGMP for $8M. Abzena has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).
Join Mergr and gain access to Abzena’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 1